MEL AVIATION LIMITED
Company number 00939400 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: MEL Aviation Limited
1. Financial Health Score: B+
Explanation: MEL Aviation Limited presents as a fundamentally robust patient with a strong constitution built over 56 years of trading. The balance sheet shows consistent growth in net assets, profitability across all subsidiaries, and a healthy cash position. However, there are symptoms that warrant monitoring: a notable decline in turnover, a significant drop in cash reserves from their 2023 peak, and elevated debtor days suggesting potential circulatory issues in cash collection. The exceptional expenses of £1.04m in 2024 represent an acute condition that, while treatable, has impacted the bottom line.
2. Key Vital Signs
Balance Sheet Strength — Strong Pulse
| Metric | 2024 | 2023 | 2020 | 2017 |
|---|---|---|---|---|
| Net Assets | £24.8M | £24.1M | £23.9M | £22.0M |
| Total Assets | £34.5M | £40.1M | £33.2M | £30.6M |
| Cash | £5.9M | £10.2M | £5.0M | £2.9M |
Interpretation: Net assets have grown steadily from £22.0M in 2017 to £24.8M in 2024 — a healthy, compounding heartbeat averaging approximately £400k annual growth. This indicates the business is retaining earnings and building equity, much like steady weight gain in a growing child rather than unhealthy bloating.
Profitability — Healthy but Weakening
| Metric | 2024 | 2023 |
|---|---|---|
| Turnover | £29.15M | £33.91M |
| Gross Margin | 34.5% | 32.1% |
| Operating Profit (pre-exceptional) | £3.5M | £4.8M |
| Exceptional Expenses | £1.04M | Nil |
| Profit Before Tax (Parent) | £1.4M | £4.3M |
Interpretation: The gross margin improvement from 32.1% to 34.5% is an encouraging vital sign — the business is extracting more value from each pound of revenue. However, the 14% decline in turnover and the £1.04m exceptional expenses have acted like a sudden infection, reducing operating profit significantly. The directors attribute the turnover decline to one-off MOD work in the prior year, which, if accurate, suggests the underlying revenue base remains stable.
Liquidity & Cash Flow — Moderate Concern
| Metric | 2024 | 2023 | Trend |
|---|---|---|---|
| Cash | £5.9M | £10.2M | ▼ 42% decline |
| Debtors Days | 97 days | 95 days | ▲ Slight deterioration |
| Creditors Days | 67 days | 114 days | ▼ Significant decrease |
Interpretation: The cash position has fallen sharply from its 2023 peak of £10.2M, though it remains well above 2019 levels of £2.3M. The dramatic reduction in creditors days from 114 to 67 suggests the group has deliberately paid down supplier balances — this explains both the cash reduction and the significant decrease in total liabilities from £15.9M to £9.6M. This is akin to a patient paying off existing debts while maintaining a reasonable emergency fund.
The debtor days at 97 remain elevated. For context, in the aviation and MOD supply sector, longer payment terms are common, but nearly three months of revenue tied up in debtors represents a strain on the circulatory system.
Leverage & Gearing — Improving
| Year | Total Liabilities | Net Assets | Gearing Ratio |
|---|---|---|---|
| 2024 | £9.6M | £24.8M | 38.7% |
| 2023 | £15.9M | £24.1M | 66.0% |
| 2019 | £5.1M | £23.6M | 21.6% |
Interpretation: The 2023 spike in liabilities to £15.9M (gearing of 66%) was a temporary inflammation that has now subsided to a more comfortable 38.7%. This appears to have been working capital-related rather than long-term debt, and the group has effectively treated this condition by reducing liabilities by £6.3M in a single year.
3. Diagnosis
Overall Financial Condition: Fundamentally Sound with Areas Requiring Attention
What the Financial Data Reveals:
Healthy Tissues: - Consistent Equity Growth: Net assets have grown every year from £22.0M (2017) to £24.8M (2024), demonstrating reliable long-term value creation. This is the financial equivalent of a patient maintaining a healthy weight over decades. - Diversified Subsidiary Portfolio: All five subsidiaries traded profitably in 2024, with Arrowsmith Engineering (£709k PBT), Headset Services (£250k PBT), MEL Aviation GmbH (£268k profit vs prior year loss), and SMA Plastics (£56k PBT) all contributing positively. This diversification acts as an immune system — weakness in one area is offset by strength in others. - Margin Improvement: The gross margin increase to 34.5% indicates pricing power and operational efficiency improvements, a sign of underlying commercial health. - Debt Reduction: The group has proactively reduced liabilities by approximately £6.3M, strengthening the balance sheet and reducing financial risk.
Symptoms of Concern: - Revenue Contraction: The 14% turnover decline from £33.91M to £29.15M, even if partly attributable to one-off MOD work, represents lost volume. If the 2025 turnover does not recover, this could indicate a chronic rather than acute condition. - Exceptional Expenses: The £1.04m exceptional write-downs and provisions represent an unusual event that warrants scrutiny. While one-off in nature, such expenses can sometimes mask underlying operational issues or indicate management judgments about asset quality. - Elevated Debtors: At 97 days, debtors represent approximately £7.7M tied up in unpaid invoices. This is the financial equivalent of poor circulation — blood (cash) is not flowing efficiently through the system. - Cash Volatility: The swing from £10.2M to £5.9M in cash, while partly explained by liability reduction, represents significant volatility that could constrain the group's ability to respond to unexpected challenges.
Underlying Health Indicators: - The group operates in a specialist aviation engineering niche (SIC 71129) with MOD and civil aviation clients — a sector with high barriers to entry but also exposure to government procurement cycles. - The Serbian manufacturing facility provides cost-base protection, acting as a preventative measure against margin erosion. - The group holds CAA approvals, suggesting regulatory compliance and quality credentials that protect competitive position.
4. Recommendations
Immediate Actions (Next 6 Months)
1. Debtor Management — Improve Circulation - Target reducing debtor days from 97 to below 80 days. This would release approximately £1.4M of cash into the system. - Implement structured credit control procedures with monthly aging reviews. - Consider offering early payment discounts to MOD clients where contractually permissible.
2. Investigate Exceptional Expenses — Diagnostic Tests Required - Obtain full transparency on the £1.04m exceptional write-downs and provisions. - Determine whether these relate to specific contracts, asset impairments, or restructuring costs. - Assess whether any further exceptional charges are anticipated in 2025.
3. Cash Flow Forecasting — Regular Check-ups - Develop rolling 13-week cash flow forecasts given the volatility observed. - The cash reduction of £4.3M in a single year, even if partly strategic, warrants closer monitoring.
Medium-Term Actions (6-18 Months)
4. Revenue Recovery Plan — Rehabilitation Programme - Develop a clear pipeline analysis distinguishing recurring revenue from one-off contracts. - Set specific targets for 2025 turnover that account for the MOD work normalization. - Invest in business development for the German subsidiary (MEL Aviation GmbH) which has moved from loss to profit — this represents a growth opportunity.
5. Working Capital Optimization — Lifestyle Adjustments - The shift in creditors days from 114 to 67 suggests deliberate acceleration of supplier payments. Review whether this was optimal or whether extended terms could be negotiated without damaging supplier relationships. - Maintain cash reserves above £4M as a minimum buffer — approximately 1.6 months of operating costs based on current run rates.
6. Succession and Governance — Preventative Care - With key PSCs (Gary Walter Harvey and Nicholas Francis Smith) holding significant control and directorship roles, ensure robust succession planning is in place. - The trust structure (Mel Aviation Trustee Limited owning 50-75%) provides continuity, but documented succession plans remain essential for a business of this scale and age.
Long-Term Strategic Considerations (18+ Months)
7. Capital Allocation Strategy — Long-Term Wellness Plan - With £24.8M in net assets and strong profitability, the group has capacity for strategic investment. Consider whether capital should be directed toward: - Organic growth in emerging aviation technologies (eVTOL, drone systems) - Complementary acquisitions - Enhanced manufacturing capacity in Serbia - Property investment (the group holds significant freehold assets)
8. Risk Diversification — Building Immune Resilience - While MOD contracts provide stability, they also create concentration risk. Continue developing civil aviation and international revenue streams. - Monitor geopolitical risks that could affect both MOD procurement patterns and supply chains.
Summary Financial Dashboard
| Vital Sign | Reading | Status |
|---|---|---|
| Net Assets Growth | £22.0M → £24.8M (2017-2024) | ✅ Healthy |
| Gross Margin | 34.5% (improving) | ✅ Healthy |
| Operating Profit Margin | ~12% (pre-exceptional) | ⚠️ Moderate |
| Cash Position | £5.9M (volatile) | ⚠️ Monitor |
| Gearing Ratio | 38.7% (improving) | ✅ Healthy |
| Debtor Days | 97 days | ⚠️ Elevated |
| Subsidiary Performance | All profitable | ✅ Healthy |
| Turnover Trend | -14% YoY | ⚠️ Concern |